共 353 条
[1]
Nebert D(2008)From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions Drug Metab Rev 40 187-224
[2]
Zhang G(2008)Epigenomics and breast cancer Pharmacogenomics 9 1879-1902
[3]
Vesell E(2012)Hermsen. M.A. Hypomethylation of LINE-1, and not centromeric SAT-α, is associated with centromeric instability in head and neck squamous cell carcinoma Cell Oncol 35 259-67
[4]
Lo PK(2012)Soleimani. M. Aberrant microRNA expression and its implications in the pathogenesis of leukemias Cell Oncol 35 317-34
[5]
Sukumar S(2013)miRNAs in head and neck cancer revisited Cell Oncol 36 1-7
[6]
Martínez JG(2010)MicroRNAs and their implications in toxicological research Toxicol Lett 198 100-105
[7]
Pérez-Escuredo J(2008)MiRNSPs or MiR polymorphisms, new players in microRNA mediated regulation of the cell Cell Cycle 7 853-858
[8]
Castro-Santos P(2009)MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and personalized medicine Pharmacogenomics 10 399-416
[9]
Marcos CA(2010)Epigenetic architecture and miRNA: reciprocal regulators Epigenomics 6 823-840
[10]
Pendás JL(2013)Epigenetic drug combination induces genome-wide demethylation and altered gene expression in neuro-ectodermal tumor-derived cell lines Cell Oncol 36 351-62